Mitochondrion dysfunctions in early PD, page-4

Pivalde....Certainly hope you are correct. For sure, that would be THE BEST Christmas present for we long-term investors! And, just in time to solve our Nasdaq non-compliance problem before the February, 2023 deadline extension. It makes sense that they requested the extension if they were confident that very positive news regarding PBT2 would probably be announced by then. No need for reverse split dilution or other emergency measures in the interim. Besides, if there is some kind of problem or delay, I'm sure all of the Company principals will gladly take pay cuts, or collectively withdraw from their million dollar bank accounts, or even sell some of their personal Company stock shares to temporarily subsidize our important and ongoing development efforts!! Ya think?!